Breadcrumb

What's New at the RI-MUHC ?

New insights into the genetics of rare diseases

RI-MUHC team builds a new model to study Nager and Rodriguez syndromes, revealing crucial information about the role of the SF3B4 gene

New advances in lung cancer treatment

International clinical trial shows perioperative immunotherapy prolongs life in non-small-cell lung cancer patients.

New progress in personalizing treatment of sarcoma using AI

RI-MUHC researcher leads the development of the first multimodal deep learning model to optimize care for individual cancer patients

The elderly still take too many potentially inappropriate drugs

Study shows that despite some improvements, potentially inappropriate medications are still heavily prescribed to seniors in Canada and some are...

Bridging science and care: Enhancing parenting interventions for early childhood development

RI-MUHC researcher Marilyn Ahun publishes new work on the effects of multi-component parenting and mental...

New guidelines to better identify people at risk of heart attack and stroke

An international expert panel, co-chaired by Dr. Rhian Touyz of the RI-MUHC, recommends various measures...

RI-MUHC researchers introduce a scalable, cost-effective solution for single-cell profiling

An innovative computational tool, scSemiProfiler, makes powerful single-cell sequencing technology more...

Circadian rhythms appear to influence vulnerability to malaria parasites

A new discovery could lead to more effective treatment of malaria and other parasitic diseases.

Introducing peanuts earlier to reduce allergy risk

A recent study by the Research Institute of the McGill University Health Centre, using data from the Montreal Children's Hospital, reveals that introducing...

Dream discovery: Melatonin’s key role in REM sleep revealed

A significant breakthrough in the understanding of sleep mechanism opens new promise for treating sleep disorders and associated...

Learn more about the RI-MUHC